Press Release – Page 4 – Jecho Laboratories, Inc.

Jecho Laboratories, Inc. Announces Abstract Selected for Poster Presentation at the 16th Annual World ADC Congress

Post author:Jecho
Post published:November 3, 2025
Post category:Press Release

November 3, 2025 Frederick, MD - Jecho Laboratories, Inc. will present emerging preclinical data on JLC059, a novel GPC3/PD-L1 bispecific antibody drug conjugate (bsADC) at the 16th Annual World ADC…

Jecho Laboratories, Inc. Announces Late-Breaking Abstract Selected for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Post author:Jecho
Post published:October 30, 2025
Post category:Press Release

October 30, 2025 Frederick, MD - Jecho Laboratories, Inc. will present emerging clinical data from a Phase 1 study of JL18008, an innovative IL-7/HSA fusion protein for HIV immunological non-responders…

Jecho Biopharmaceuticals Makes Another Breakthrough with Innovative Drug JL19001, Celebrating National Day with a Scientific Milestone

Post author:Jecho
Post published:October 1, 2025
Post category:Press Release

Oct 01, 2025 Tianjin, China – Jecho Biopharmaceuticals Co., Ltd. (hereinafter referred to as “Jechobio”) has made another breakthrough in independently developed innovative drugs, offering a tribute to the National…